| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8235514 | International Journal of Radiation Oncology*Biology*Physics | 2009 | 7 Pages |
Abstract
Dose escalation, accelerated fractionation, and combined modality therapies improve outcomes in SCC of the lung. Our review of the literature highlights the different natural history for SCC vs. other non-small cell lung cancers and emphasizes the importance of tailoring treatment strategies to individual patients. At the University of Florida, we have begun treating unresectable Stage III patients with SCC of the lung using 69.6 Gy twice daily with concurrent chemotherapy.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Heather E. M.D., Meera Iyengar, Christopher G. M.S., Kenneth M.D.,